Breast Cancer
News
BMN 673 monotherapy makes splash in BRCA-mutated ovarian, breast cancer
Major finding: The RECIST response rate was 44% for breast and ovarian cancer patients.Data source: Ongoing phase I/II study in ovarian and breast...
News
Oral therapy for metastatic breast cancer grows in Medicare patients
Major finding: In patients enrolled in Medicare Part D, fulvestrant was the most common first-line treatment given to 9.1% of patients, but oral...
News
Everolimus effective in women with early failure of adjuvant therapy
Major finding: Median progression-free survival was 11.5 months in the everolimus-plus-exemestane group and 4.1 months in the placebo-plus...
Conference Coverage
ASTRO outlines five radiation oncology practices that should be curtailed
News
Genetic alterations may predict everolimus efficacy
Major finding: In a secondary analysis, patients with one or no alterations in four genes had a 73% improvement in progression-free survival with...
News
USPSTF breast cancer chemoprevention recommendations: We’re in this together
Major finding: Asymptomatic women without a prior diagnosis of breast cancer, ductal carcinoma in situ, or lobular carcinoma in situ who are at...
Conference Coverage
Breast cancer receptor change may predict outcomes
Major finding: Receptor status changed in 41% of breast cancers after neoadjuvant chemotherapy.
Research
Assessment of physician compliance to liver function test monitoring guidance for patients treated with lapatinib
Commentary
Keep your patents off my genes!
News
FDA approves first generic capecitabine
News
Fear, anxiety drive contralateral mastectomy, survey finds
Major finding: A total of 94% of respondents cited a desire to improve survival as an extremely or very important factor in their decision to...